72 related articles for article (PubMed ID: 24950407)
1. Structural characterization of the BH3-like motif of hepatitis B virus X protein.
Kusunoki H; Tanaka T; Kohno T; Wakamatsu K; Hamaguchi I
Biochem Biophys Res Commun; 2014 Jul; 450(1):741-5. PubMed ID: 24950407
[TBL] [Abstract][Full Text] [Related]
2. Structural and biochemical analysis of Bcl-2 interaction with the hepatitis B virus protein HBx.
Jiang T; Liu M; Wu J; Shi Y
Proc Natl Acad Sci U S A; 2016 Feb; 113(8):2074-9. PubMed ID: 26858413
[TBL] [Abstract][Full Text] [Related]
3. Structural and functional analyses of hepatitis B virus X protein BH3-like domain and Bcl-xL interaction.
Zhang TY; Chen HY; Cao JL; Xiong HL; Mo XB; Li TL; Kang XZ; Zhao JH; Yin B; Zhao X; Huang CH; Yuan Q; Xue D; Xia NS; Yuan YA
Nat Commun; 2019 Jul; 10(1):3192. PubMed ID: 31324803
[TBL] [Abstract][Full Text] [Related]
4. Expression, purification and characterization of hepatitis B virus X protein BH3-like motif-linker-Bcl-x
Kusunoki H; Tanaka T; Kohno T; Kimura H; Hosoda K; Wakamatsu K; Hamaguchi I
Biochem Biophys Rep; 2017 Mar; 9():159-165. PubMed ID: 29114584
[TBL] [Abstract][Full Text] [Related]
5. Chemical shift assignments of a fusion protein comprising the C-terminal-deleted hepatitis B virus X protein BH3-like motif peptide and Bcl-x
Kusunoki H; Hamaguchi I; Kobayashi N; Nagata T
Biomol NMR Assign; 2022 Oct; 16(2):357-361. PubMed ID: 36044106
[TBL] [Abstract][Full Text] [Related]
6. NMR characterization of the interaction between Bcl-x
Kusunoki H; Tanaka T; Kohno T; Kimura H; Hosoda K; Wakamatsu K; Hamaguchi I
Biochem Biophys Res Commun; 2019 Oct; 518(3):445-450. PubMed ID: 31439373
[TBL] [Abstract][Full Text] [Related]
7. Structural Insights into the Interaction between the C-Terminal-Deleted BH3-like Motif Peptide of Hepatitis B Virus X Protein and Bcl-x
Kusunoki H; Sakamoto T; Kobayashi N; Kohno T; Wakamatsu K; Nagata T
Biochemistry; 2024 Mar; 63(5):632-643. PubMed ID: 38377677
[TBL] [Abstract][Full Text] [Related]
8. Relationship between helix stability and binding affinities: molecular dynamics simulations of Bfl-1/A1-binding pro-apoptotic BH3 peptide helices in explicit solvent.
Modi V; Lama D; Sankararamakrishnan R
J Biomol Struct Dyn; 2013; 31(1):65-77. PubMed ID: 22803956
[TBL] [Abstract][Full Text] [Related]
9. Nuclear magnetic resonance study of protein-protein interactions involving apoptosis regulator Diva (Boo) and the BH3 domain of proapoptotic Bcl-2 members.
Santiveri CM; Sborgi L; de Alba E
J Mol Recognit; 2012 Dec; 25(12):665-73. PubMed ID: 23192964
[TBL] [Abstract][Full Text] [Related]
10. Hepatitis B virus X protein targets Bcl-2 proteins to increase intracellular calcium, required for virus replication and cell death induction.
Geng X; Huang C; Qin Y; McCombs JE; Yuan Q; Harry BL; Palmer AE; Xia NS; Xue D
Proc Natl Acad Sci U S A; 2012 Nov; 109(45):18471-6. PubMed ID: 23091012
[TBL] [Abstract][Full Text] [Related]
11. Molecular dynamics simulations of pro-apoptotic BH3 peptide helices in aqueous medium: relationship between helix stability and their binding affinities to the anti-apoptotic protein Bcl-X(L).
Lama D; Sankararamakrishnan R
J Comput Aided Mol Des; 2011 May; 25(5):413-26. PubMed ID: 21523491
[TBL] [Abstract][Full Text] [Related]
12. Synthesis and helical structure of lactam bridged BH3 peptides derived from pro-apoptotic Bcl-2 family proteins.
Yang B; Liu D; Huang Z
Bioorg Med Chem Lett; 2004 Mar; 14(6):1403-6. PubMed ID: 15006371
[TBL] [Abstract][Full Text] [Related]
13. Peptide screening to knockdown Bcl-2's anti-apoptotic activity: implications in cancer treatment.
Raghav PK; Verma YK; Gangenahalli GU
Int J Biol Macromol; 2012 Apr; 50(3):796-814. PubMed ID: 22155216
[TBL] [Abstract][Full Text] [Related]
14. Human hepatitis B virus X protein induces apoptosis in HepG2 cells: role of BH3 domain.
Lu YW; Chen WN
Biochem Biophys Res Commun; 2005 Dec; 338(3):1551-6. PubMed ID: 16274670
[TBL] [Abstract][Full Text] [Related]
15. A comparison of two strategies for affinity maturation of a BH3 peptide toward pro-survival Bcl-2 proteins.
Zhang S; Long A; Link AJ
ACS Synth Biol; 2012 Mar; 1(3):89-98. PubMed ID: 23651073
[TBL] [Abstract][Full Text] [Related]
16. Interaction of a putative BH3 domain of clusterin with anti-apoptotic Bcl-2 family proteins as revealed by NMR spectroscopy.
Lee DH; Ha JH; Kim Y; Bae KH; Park JY; Choi WS; Yoon HS; Park SG; Park BC; Yi GS; Chi SW
Biochem Biophys Res Commun; 2011 May; 408(4):541-7. PubMed ID: 21527247
[TBL] [Abstract][Full Text] [Related]
17. Locating Herpesvirus Bcl-2 Homologs in the Specificity Landscape of Anti-Apoptotic Bcl-2 Proteins.
Foight GW; Keating AE
J Mol Biol; 2015 Jul; 427(15):2468-2490. PubMed ID: 26009469
[TBL] [Abstract][Full Text] [Related]
18. Hepatitis B virus X protein targets the Bcl-2 protein CED-9 to induce intracellular Ca2+ increase and cell death in Caenorhabditis elegans.
Geng X; Harry BL; Zhou Q; Skeen-Gaar RR; Ge X; Lee ES; Mitani S; Xue D
Proc Natl Acad Sci U S A; 2012 Nov; 109(45):18465-70. PubMed ID: 23091037
[TBL] [Abstract][Full Text] [Related]
19. Membrane-insertion fragments of Bcl-xL, Bax, and Bid.
García-Sáez AJ; Mingarro I; Pérez-Payá E; Salgado J
Biochemistry; 2004 Aug; 43(34):10930-43. PubMed ID: 15323553
[TBL] [Abstract][Full Text] [Related]
20. Vaccinia virus anti-apoptotic F1L is a novel Bcl-2-like domain-swapped dimer that binds a highly selective subset of BH3-containing death ligands.
Kvansakul M; Yang H; Fairlie WD; Czabotar PE; Fischer SF; Perugini MA; Huang DC; Colman PM
Cell Death Differ; 2008 Oct; 15(10):1564-71. PubMed ID: 18551131
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
